The influence of organizational stigmatization on legitimacy claims in CSR disclosures

Harsh Jha, Andrew Kozhevnikov, B Liu

    Research output: Chapter in Book/Report/Conference proceedingConference proceedingpeer-review

    Abstract

    This paper explores the undertheorized relationship between organizational stigma and corporate reputation, specifically how legitimate accounts are constructed in CSR disclosures in order to enhance corporate reputation, when facing episodes of intense stigma. Following single case study method, we qualitatively examine fourteen CSR reports released by the leading pharmaceutical firm GSK during the period of 2002-2015. Then, we analyse the influence of three episodes of intense stigmatization faced by GSK – Paxil, Avandia and China bribery scandals – on the salience of various themes induced from CSR reports. Our findings suggest that increase in intensity of public stigmatization of a firm may have a positive influence on the variety of themes included in CSR disclosures, targeting various bases of legitimacy – regulatory, associational and moral, and increase in dominance of moral legitimacy claims, over time.
    Original languageEnglish
    Title of host publicationAcademy of Management Annual Meeting Proceedings
    PublisherAcademy of Management
    Volume18
    DOIs
    Publication statusPublished - 1 Aug 2018
    Event78th Annual Meeting of the Academy of Management: Improving Lives - Chicago, United States
    Duration: 10 Aug 201814 Aug 2018
    Conference number: 78
    https://connect.aom.org/aom2018/home

    Conference

    Conference78th Annual Meeting of the Academy of Management
    Abbreviated title2018 AOM Annual Meeting
    Country/TerritoryUnited States
    CityChicago
    Period10/08/1814/08/18
    Internet address

    Fingerprint

    Dive into the research topics of 'The influence of organizational stigmatization on legitimacy claims in CSR disclosures'. Together they form a unique fingerprint.

    Cite this